Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fabio Marra
Observed name:
F. Marra
Institutions:
Azienda Ospedaliero-Universitaria Careggi,
University of Florence
Observed institutions:
Azienda Ospedaliero-Universitaria Careggi,
University of Florence
ORCID:
0000-0001-8629-0878
Observed ORCID:
0000-0001-8629-0878
OpenAlex ID:
A5018056699
Expression of Monocyte Chemotactic Protein-1 Precedes Monocyte Recruitment in a Rat Model of Acute Liver Injury, and is Modulated by Vitamin E
1999
·
Fabio Marra
, Raffaella DeFranco
, et al.
·
Journal of Investigative Medicine
·
103
La steatosi epatica non alcolica: una nuova insidia per il cardiologo
2010
·
Roberto Tarquini
, Chiara Lazzeri
, et al.
·
Giornale italiano di cardiologia
·
21
PDF
Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma
2026
·
Jean-Charles Nault
, Claudia Campani
, et al.
·
Journal of Hepatology
·
8
PDF
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study
2026
·
Elisa Pinto
, Filippo Pelizzaro
, et al.
·
Alimentary Pharmacology & Therapeutics
·
7
Long-term outcomes of atezolizumab–bevacizumab in unresectable hepatocellular carcinoma: A real-world study
2026
·
Francesco Tovoli
, Massimo Iavarone
, et al.
·
Hepatology
·
5
Prevention of Portal Hypertension Complications Beyond Primary TIPS Indication Is Independent of Endoprosthesis Under‐Dilation
2026
·
Davide Roccarina
, Dario Saltini
, et al.
·
Liver International
·
4
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
2026
·
Erwan Vo-Quang
, Claudia Campani
, et al.
·
European Journal of Cancer
·
2
Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF)
2026
·
Stefano Gitto
, Filippo Gabrielli
, et al.
·
Digestive and Liver Disease
·
1
PDF
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis
2024
·
S. Nardelli
, O. Riggio
, et al.
·
Digestive and Liver Disease
·
1
Silent but present: a case of Chagas disease-related megaoesophagus diagnosed in a non-endemic setting
2026
·
Virginia Donini
, Anna Barbiero
, et al.
·
Journal of Travel Medicine
The prognostic impact of comorbidities in patients with hepatocellular carcinoma: a multicenter observational study
2025
·
F. Pelizzaro
, E. Pinto
, et al.
·
Digestive and Liver Disease
Assessment of sarcopenia improves the prediction of post-TIPS mortality in older adult patients with cirrhosis
2024
·
D. Saltini
, S. Nardelli
, et al.
·
Digestive and Liver Disease
189P The synergic effect of metformin and atezolizumab/bevacizumab in diabetic HCC patients: A retrospective study from ARTE multicentric Italian dataset
2024
·
A. Dalbeni
, A. Auriemma
, et al.
·
Annals of Oncology
PDF
Liver function is a predictor of survival in patients with hepatocellular carcinoma in best supportive care
2023
·
C. Campani
, L. Bucci
, et al.
·
Digestive and Liver Disease
Predictors of survival of patients with hepatocellular carcinoma in best supportive care
2022
·
C. Campani
, L. Bucci
, et al.
·
Digestive and Liver Disease
Show more works
View as search
Works count:
15
Citation count:
152
H-index:
5
I10-index:
2
Year
Topic
Type